ATIM-27. TUMOR MUTATIONAL BURDEN PREDICTS RESPONSE TO ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) IN MALIGNANT GLIOMA PATIENTS: ASSESSMENT OF TRANSCRIPTIONAL AND IMMUNOLOGICAL CORRELATES

BACKGROUND: The live attenuated oral poliovirus vaccine was modified to contain a heterologous internal ribosomal entry site stemming from human rhinovirus type 2, creating PVSRIPO. PVSRIPO recognizes CD155, an oncofetal cell adhesion molecule and tumor antigen widely expressed ectopically in malign...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Gromeier, Matthias, Brown, Michael, Beuabier, Nike, Yan, Hai, He, Yiping, Zhang, Gao, Desjardins, Annick, Herndon, James, Bolognesi, Dani, Friedman, Allan, Friedman, Henry, McSherry, Frances, Lin, Xiang, Wei, Zhi, Nair, Smita, Peters, Katherine, Randazzo, Dina, Sampson, John, McLendon, Roger, Bigner, Darell, Ashley, David
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2019
Soggetti:
Adult Clinical Trials–Immunologic
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847607/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.026
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi